Glaukos (NYSE:GKOS) posted first-quarter results that beat the overall consensus on Wall Street. The San Clemente, Calif.-based ophthalmic medical technology company yesterday reported losses of -$16.469 million, or -36¢ per share, on sales of $67.968 million for the three months ended March 31, for a sales growth of 22.83% compared with Q1 2020. Adjusted to […]
Vision
Staar Surgical rises on 44% sales growth in Q1 result
Staar Surgical (NSDQ:STAA) posted first-quarter results that beat the overall consensus on Wall Street. The Lake Forest, Calif.-based implantable eye lenses company yesterday reported profits of $4.99 million, or 10¢ per share, on sales of $50.75 million for the three months ended April 2, for a sales growth of 44.24% compared with Q1 2020. Adjusted to […]
9 medical devices you should keep an eye out for in 2021
The medical device industry weathered the COVID-19 pandemic well — and is now set to roll out a host of innovations in 2021. Economists generally expect the U.S. to see a boom as we emerge from the pandemic and resulting recession. Medtech companies appear set to ride the wave this year, with plans to seek approval or […]
Cardiovascular Systems completes minority investment in CarePICS with option to buy
Cardiovascular Systems (NSDQ:CSII) announced that it completed a minority investment and entered into an option agreement to acquire telehealth company CarePICS. CarePICS offers a virtual care platform designed to aid in the treatment of people with peripheral artery disease (PAD), critical limb ischemia (CLI) and lower extremity wounds, according to a news release. The platform […]
Corza Medical set to take on ‘almost monopolistic’ surgical giants
Corza Medical, a new venture forged by the financial firepower of private equity giant GTCR, is looking to become a surgical tool supplier that its executive chairman Greg Lucier says can compete with “almost monopolistic” leaders in the space. To mount the challenge, Corza acquired Surgical Specialties Corp., a supplier of surgical sutures and ophthalmic […]
Alcon slides on missed Q2 earnings
Alcon (NYSE:ALC) shares dipped before hours today on second-quarter results that missed the consensus earnings forecast. The Geneva, Switzerland-based company posted losses of -$422 million, or -86¢ per share, on sales of $1.2 billion for the three months ended June 30, 2020, for an 8.2% bottom-line slide on a sales decline of -36.2%. Adjusted to exclude […]
The 18 most innovative medical devices of 2020
The Galien Foundation recently announced nominees for most innovative medical devices for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical and technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien process, we are honored […]
Second Sight Medical schedules auction of its assets
The assets of Second Sight Medical (NSDQ:EYES) are going up for auction on June 25. The developer and manufacturer of implantable visual prosthetics for blind individuals created the only FDA-approved implantable visual prosthetic treatment for severe retinitis pigmentosa. The company said in March that it was winding down its operations amid the financial shock of the COVID-19 pandemic. […]
Cochlear wins FDA approval to lower age to implant to 9 months
Cochlear Ltd. (ASX:COH) has received FDA approval to lower the age of cochlear implantation to nine months for children. The new approval lowers the age from the original 12 months for children with bilateral, profound sensorineural hearing loss. Cochlear implants have been FDA approved for use in children since 1990. “In light of all that has […]
Mojo Vision developing ‘smart’ contact lens
Mojo Vision is working with the FDA to develop a smart contact lens to help people with low vision. The lens overlays real-time contrast and lighting enhancements with zoom functionality and recently won FDA breakthrough device designation. “Receiving the Breakthrough Device Designation is a significant step in our research and development process. We look forward […]
J&J Vision launches Tecnis Toric II intraocular lens in U.S.
Johnson & Johnson (NYSE:JNJ) Vision announced that, after winning FDA approval, it launched the Tecnis Toric II one-piece intraocular lens (IOL) to treat astigmatism in cataract patients. The Tecnis Toric II IOL is Johnson & Johnson Vision’s first approved product within the Tecnis Toric II platform, which offers more surface texture and friction on IOL haptics, […]
